Vaccines, Viral Vectors & Biologics / Drug Substance & Drug Product — CDMO
IDT Biologika is a CDMO for vaccines, viral vectors for cell & gene therapies, and virus-like particles, and offers sterile fill-finish for other biologics. On its 100th anniversary and having expanded to the US, IDT felt its scientific strength was not being recognized.
We identified IDT Biologika’s relationships with Big Pharma over two decades to develop and manufacture some of the world’s most critical vaccines, including tuberculosis, malaria, and Ebola. We then worked with many IDT scientific SMEs in Germany and the US to build content that showed far more of its technical depth.
IDT was recognized for its leadership in vaccines and selected as a strategic 5-year Government partner for pandemic preparedness, with the capacity and ability to develop and manufacture 80 million doses of vector vaccine per year.
